Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000153241 | SCV000151163 | likely benign | not specified | 2014-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000512944 | SCV000196823 | benign | not provided | 2019-07-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 11741828, 16344347, 22451200, 16717227, 18832576, 27884173, 29065428, 28482373, 32403337) |
Eurofins Ntd Llc |
RCV000153241 | SCV000202715 | benign | not specified | 2014-02-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081194 | SCV000559445 | likely benign | Walker-Warburg congenital muscular dystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000512944 | SCV000603720 | likely benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000512944 | SCV000608913 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | FKRP: BS2 |
Counsyl | RCV000672414 | SCV000797516 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2018-01-30 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852754 | SCV000995472 | benign | Primary dilated cardiomyopathy; Cardiomyopathy; Hypertrophic cardiomyopathy | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000672414 | SCV001141108 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000153241 | SCV002103979 | benign | not specified | 2024-01-29 | criteria provided, single submitter | clinical testing | Variant summary: FKRP c.427C>A (p.Arg143Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0052 in 1493634 control chromosomes in the gnomAD database (v4.0.0), including 31 homozygotes. The observed variant frequency is approximately 2 fold of the estimated maximal expected allele frequency for a pathogenic variant in FKRP causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.0024), strongly suggesting that the variant is benign. c.427C>A has been reported in the literature in individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (examples: Sframeli_2017, Brockington_2001). These report(s) do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28688748, 11741828). ClinVar contains an entry for this variant (Variation ID: 129057). Based on the evidence outlined above, the variant was classified as benign. |
Ambry Genetics | RCV002326812 | SCV002630041 | likely benign | Cardiovascular phenotype | 2018-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002498510 | SCV002812635 | likely benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1; Muscular dystrophy-dystroglycanopathy type B5; Autosomal recessive limb-girdle muscular dystrophy type 2I; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2022-04-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000512944 | SCV005209714 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000672414 | SCV002088951 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2019-11-08 | no assertion criteria provided | clinical testing |